Advertisements



Medtronic initiates clinical study to assess safety of drug-eluting stents

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2018

Inovio Initiates Phase II Study on Pipeline Drug VGX-3100

Inovio (INO) begins a phase II study to evaluate the efficacy of its pipeline candidate VGX-3100 on adult men and women with human papilloma virus (HPV)-related anal dysplasia. Inovio Pharmaceuticals, INO has initiated a .....»»

Category: dealsSource: nytMay 22nd, 2018

Nektar initiates Phase 1b clinical study of NKTR-358

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 8th, 2018

Catalyst Enrolls First Patient in Phase III Firdapse Study

Catalyst (CPRX) enrolls the first patient in its phase III clinical trial (MSK-002) to evaluate the efficacy and safety of Firdapse in patients with MuSK antibody positive Myasthenia Gravis. Catalyst Pharmaceuticals, Inc. CPRX, enroled.....»»

Category: worldSource: nytApr 20th, 2018

Epizyme (EPZM) Publishes Tazemetostat Phase I Data, Stock Up

Epizyme (EPZM) publishes tazemetostat phase I clinical data in The Lancet Oncology. The study demonstrated favorable safety findings and anti-tumor activity. Shares of .....»»

Category: dealsSource: nytApr 11th, 2018

Esperion Aces Third Study, Shows That Safety Issues Were Overblown

Esperion Aces Third Study, Shows That Safety Issues Were Overblown.....»»

Category: topSource: seekingalphaMay 24th, 2018

Heart, diabetes devices pump up Medtronic"s quarterly profit

Sales in the cardiac and vascular unit, which sells defibrillators, pace-makers, heart valves and stents, jumped 10.1 percent to $3.14 billion in the fourth quarter......»»

Category: topSource: foxnewsMay 24th, 2018

Check-Cap announces publication from clinical study of C-Scan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 22nd, 2018

Roche (RHHBY) Announces Positive Data on Hemophilia Drug

Roche (RHHBY) announces positive data from two phase III studies on hemophilia drug Hemlibra which has further strengthened its hemophilia portfolio. Roche RHHBY announced full results from the phase III study, HAVEN 3, evaluating haemo.....»»

Category: dealsSource: nytMay 21st, 2018

Precigen announces first patient dosed in Phase 1 clinical study of INXN-4001

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 21st, 2018

Microbot Medical completes pre-clinical study for Self-Cleaning Shunt

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 21st, 2018

Pfizer"s Epilepsy Drug Lyrica Succeeds in Pediatric Study

Zacks.....»»

Category: topSource: redinewsMay 19th, 2018

Johnson & Johnson scraps Alzheimer"s trials on safety concerns

Johnson and Johnson said it would stop mid-stage trials testing its experimental Alzheimer's drug after observing safety issues, the latest drugmaker to abandon developing treatments for the memory-robbing disease......»»

Category: topSource: moneycentralMay 18th, 2018

Johnson & Johnson scraps Alzheimer"s trials on safety concerns

Johnson and Johnson said it would stop mid-stage trials testing its experimental Alzheimer's drug after observing safety issues, the latest drugmaker to abandon developing treatments for the memory-robbing disease......»»

Category: topSource: moneycentralMay 18th, 2018

This Tiny Cancer Drug Upstart Just Got Even More Interesting

A clinical-stage cancer drug company could be on the cusp of a second big win......»»

Category: topSource: foxnewsMay 18th, 2018

Minerva Neurosciences shares rise 5% on trial results for schizophrenia drug

Minerva Neurosciences Inc. shares rose 5.4% in premarket trade on Thursday after results from a phase 2b trial for a schizophrenia drug were published in the peer-reviewed The Journal of Clinical.....»»

Category: topSource: marketwatchMay 17th, 2018

Shorter drug treatment OK for many breast cancer patients

Many women with a common and aggressive form of breast cancer that is treated with Herceptin can get by with six months of the drug instead of the usual 12, greatly reducing the risk of heart damage it sometimes can cause, a study suggests......»»

Category: topSource: foxnewsMay 16th, 2018

No Harm in Reducing Use of Roche Drug for Breast Cancer, Study Says

Treating breast-cancer patients with an expensive Roche drug for six months instead of 12 reduced heart-related side effects without sacrificing effectiveness, a new study found......»»

Category: smallbizSource: wsjMay 16th, 2018

Sanofi Eczema Drug Dupixent Succeeds in Adolescents Study

Sanofi (SNY) announces positive results from a phase III study evaluating Dupixent for the treatment of moderate-to-severe atopic dermatiti.....»»

Category: personnelSource: nytMay 16th, 2018

Startup aims to give castoff Vertex drug new life as Alzheimer’s treatment

In 2001, Vertex Pharmaceuticals announced that it was halting development of a rheumatoid arthritis drug. The treatment, which was designed to block a certain enzyme linked to inflammation, had showed promise in clinical trials, but animal studies .....»»

Category: topSource: bizjournalsMay 16th, 2018

Atossa Genetics receives "positive" interim safety review on Endoxifen study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2018